Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites.
Roman
F J
FJ
Jouveinal Laboratoires, B.P., Fresnes, France.
Pascaud
X
X
Duffy
O
O
Vauche
D
D
Martin
B
B
Junien
J L
JL
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D006220:Haloperidol / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009478:Neuropeptide Y / Q000494:pharmacology*; D010423:Pentazocine / Q000494:pharmacology; D019894:Peptide YY; D010455:Peptides / Q000494:pharmacology*; D010620:Phenazocine / Q000031:analogs & derivatives / Q000494:pharmacology; D010622:Phencyclidine / Q000031:analogs & derivatives / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D017981:Receptors, Neurotransmitter / Q000378:metabolism*; D011957:Receptors, Opioid / Q000378:metabolism*; D017478:Receptors, Phencyclidine; D017480:Receptors, sigma
D009478:Neuropeptide Y; D010455:Peptides; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D017478:Receptors, Phencyclidine; D017480:Receptors, sigma; D019894:Peptide YY; C012134:SK&F 10047; C012058:tenocyclidine; D010620:Phenazocine; D010622:Phencyclidine; D006220:Haloperidol; D010423:Pentazocine